During the past decade, Erzsebet Gondozohaz conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 3 clinical trials were completed, i.e. on average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 3 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Erzsebet Gondozohaz" are "Chronic Cough" (2 trials), "Chronic Obstructive Pulmonary Disease" (1 trials), "Coronary Heart Disease (CHD)" (1 trials) and "Refractory and/or Unexplained Chronic Cough" (1 trials). Many other conditions were trialed in "Erzsebet Gondozohaz" in a lesser frequency.

Most popular intervention types in "Erzsebet Gondozohaz" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "BAY1817080" (1 trials), "BDP/FF/GB" (1 trials), "Evolocumab" (1 trials) and "FlF/VI + Tiotropium" (1 trials). Other intervention names were less common.

The vast majority of trials in "Erzsebet Gondozohaz" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Erzsebet Gondozohaz". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Erzsebet Gondozohaz, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Erzsebet Gondozohaz, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".